In this edition, we look at the brain-immune axis, EULAR updates and more.

Read the full coverage here:

'Brain-immune axis' implicated in simultaneous inflammation and depression, mood disorders

EULAR updates physical activity recommendations for inflammatory arthritis, OA

Study demonstrates proof-of-concept for FcRn blocker nipocalimab in lupus

'Uniquely structured' izokibep improves skin, disease activity in psoriatic arthritis

Dual-target CAR T-cell therapy exhibits 'profound' remission in systemic sclerosis

References:

Calabrese L. The science of the connection: Inflammation and mental health. Presented at: EULAR 2026 Congress; June 3-6, 2026, London.

Furie RA. Abstract LB007. Presented at: EULAR 2026 Congress; June 3-6, 2026, London.

Mease PJ. Abstract OP073. Presented at: EULAR 2026 Congress; June 3-6, 2026, London.

Rausch Osthoff AK, et al. Ann Rheum Dis. 2026;doi:10.1016/j.ard.2026.03.006.

Zhang Y. Abstract OP0311. Presented at: EULAR 2026 Congress; June 3-6, 2026, London.

In this edition, we look at new EAULAR recommendations for rheumatoid arthritis, the vagal nerve and more.

Read the full coverage here:

New EULAR recommendations for rheumatoid arthritis keep pace with 'ever-evolving field'

Calabrese: Vagal nerve stimulation a 'tectonic shift' in rheumatoid arthritis management

FDA grants fast track designation to intra-articular GLP-1 analog for knee osteoarthritis

Lupus prevention remains elusive despite new treatments

New agents, combinations make for 'exciting time' in psoriatic arthritis

References:

Calabrese LH. Psychoneuroimmunology 101; How will vagal nerve stimulation affect the rheumatologist's practice. Presented at The Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).Healio interviews

Healio interviews

Healio interviews

James JA. Novel treatments for systemic lupus erythematosus. Presented at: Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).

Kavanaugh A. Achieving precision medicine in PsA: Novel treatment strategies. Presented at The Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).

In this edition, we look at rheumatology visits impacting reproductive health counseling, restrictive Medicare Part D coverage, and more.

Read the full coverage here:

Services targeting rheumatology visits increased reproductive health counseling rates 625%

Medicare Part D coverage of certain rheumatoid arthritis drugs 'restrictive'

DMARD treatment fails to mitigate osteoporosis in rheumatoid arthritis

FDA to 'carefully shepherd' CAR T-cell therapy trials in autoimmune, rheumatic disease

Low pay, longer training requirements hobble pediatric rheumatology workforce numbers

References:

Aritomi T, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70125.

Healio interviews

Healio interviews

Kwon Y, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70132.

Marcy D, et al. Arthritis Care Res. 2026;doi:10.1002/acr.80014.